PRGO: Perrigo Company plc Stock

by  •  • Comments Off on PRGO: Perrigo Company plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,777.34
Enterprise Value ($M) 7,296.84
Book Value ($M) 4,545.30
Book Value / Share 33.32
Price / Book 0.83
NCAV ($M) -2,892.90
NCAV / Share -21.21
Price / NCAV -1.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.01
Return on Assets (ROA) -0.01
Return on Equity (ROE) -0.03

Liquidity (mrq)
Quick Ratio 1.24
Current Ratio 1.99

Balance Sheet (mrq) ($M)
Current Assets 2,959.10
Assets 10,397.30
Liabilities 5,852.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 4,655.60
Operating Income 284.50
Net Income -12.70
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 405.50
Cash from Investing -77.50
Cash from Financing -187.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G Barrow Hanley Mewhinney & Strauss Llc
02-13 13G/A Vanguard Group Inc 11.07 2.77
01-24 13G/A BlackRock Inc. 9.80 0.92

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended: September 30, 2023 ☐ TRANSITION REPORT PURSUANT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-09-09 244,632 943,805 25.92
2024-09-06 153,014 693,639 22.06
2024-09-05 130,354 535,615 24.34
2024-09-04 175,473 687,636 25.52

(click for more detail)

Similar Companies
OGN – Organon & Co. PBH – Prestige Consumer Healthcare Inc.
PFE – Pfizer Inc. QGEN – Qiagen N.V.
RCUS – Arcus Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io